Passage Bio Inc (NASDAQ: PASG) is 0.00% lower on its value in year-to-date trading and has touched a low of $0.45 and a high of $1.79 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PASG stock was last observed hovering at around $1.13 in the last trading session, with the day’s loss setting it -0.12%.
Currently trading at $1.01, the stock is 57.39% and 60.62% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.75 million and changing -10.62% at the moment leaves the stock 2.31% off its SMA200. PASG registered 60.04% gain for a year compared to 6-month loss of -18.55%. The firm has a 50-day simple moving average (SMA 50) of $0.62226 and a 200-day simple moving average (SMA200) of $0.988785.
The stock witnessed a 64.23% gain in the last 1 month and extending the period to 3 months gives it a 52.57%, and is 100.00% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 36.76% over the week and 17.27% over the month.
Passage Bio Inc (PASG) has around 58 employees, a market worth around $105.76M and $0.00M in sales. Distance from 52-week low is 123.95% and -43.58% from its 52-week high. The company has generated returns on investments over the last 12 months (-72.57%).
The EPS is expected to grow by 42.26% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Passage Bio Inc (PASG) Top Institutional Holders
53.0 institutions hold shares in Passage Bio Inc (PASG), with institutional investors hold 59.98% of the company’s shares. The shares outstanding are 61.77M, and float is at 49.14M with Short Float at 3.31%. Institutions hold 59.68% of the Float.
The top institutional shareholder in the company is ORBIMED ADVISORS LLC with over 10.12 million shares valued at $8.04 million. The investor’s holdings represent 17.9847% of the PASG Shares outstanding. As of 2024-06-30, the second largest holder is VESTAL POINT CAPITAL, LP with 6.05 million shares valued at $4.81 million to account for 10.7504 of the shares outstanding. The other top investors are LYNX1 CAPITAL MANAGEMENT LP which holds 5.06 million shares representing 8.9841% and valued at over $4.02 million, while VERSANT VENTURE MANAGEMENT, LLC holds 7.1523 of the shares totaling 4.03 million with a market value of $3.2 million.
Passage Bio Inc (PASG) Insider Activity
The most recent transaction is an insider purchase by Lynx1 Capital Management LP, the company’s 10% Owner. SEC filings show that Lynx1 Capital Management LP bought 259,998 shares of the company’s common stock on Nov 25 ’24 at a price of $0.56 per share for a total of $0.15 million. Following the purchase, the insider now owns 8.69 million shares.
Passage Bio Inc disclosed in a document filed with the SEC on Nov 26 ’24 that Lynx1 Capital Management LP (10% Owner) bought a total of 167,055 shares of the company’s common stock. The trade occurred on Nov 26 ’24 and was made at $0.71 per share for $0.12 million. Following the transaction, the insider now directly holds 8.85 million shares of the PASG stock.
Still, SEC filings show that on Nov 27 ’24, Lynx1 Capital Management LP (10% Owner) acquired 29,300 shares at an average price of $0.67 for $19663.0. The insider now directly holds 8,883,308 shares of Passage Bio Inc (PASG).
